Alpha Omega Wealth Management LLC Gilead Sciences, Inc. Transaction History

Alpha Omega Wealth Management LLC

$542 Million
Q3 2024

A detailed history of Alpha Omega Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Alpha Omega Wealth Management LLC holds 48,836 shares of GILD stock, worth $4.49 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

48,836

Previous 49,279 0.9%

Holding current value

$4.49 Million

Previous $3.38 Million 21.06%

% of portfolio

0.75%

Previous 0.65%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$66.59 - $83.99 $29,499 - $37,207	-443 Reduced 0.9%	48,836 $4.09 Million
Q2 2024 Jul 25, 2024	BUY	$63.15 - $72.88 $102,871 - $118,721	1,629 Added 3.42%	49,279 $3.38 Million
Q1 2024 Apr 17, 2024	SELL	$71.58 - $87.29 $44,809 - $54,643	-626 Reduced 1.3%	47,650 $3.49 Million
Q4 2023 Jan 30, 2024	SELL	$73.27 - $83.09 $10,990 - $12,463	-150 Reduced 0.31%	48,276 $3.91 Million
Q3 2023 Oct 11, 2023	SELL	$73.94 - $80.67 $22,329 - $24,362	-302 Reduced 0.62%	48,426 $3.63 Million
Q2 2023 Jul 28, 2023	SELL	$76.01 - $86.7 $182,043 - $207,646	-2,395 Reduced 4.68%	48,728 $3.76 Million
Q1 2023 Apr 19, 2023	SELL	$77.31 - $88.08 $258,447 - $294,451	-3,343 Reduced 6.14%	51,123 $4.24 Million
Q4 2022 Feb 01, 2023	SELL	$62.32 - $89.47 $677,667 - $972,896	-10,874 Reduced 16.64%	54,466 $4.68 Million
Q3 2022 Oct 18, 2022	SELL	$59.54 - $68.01 $57,277 - $65,425	-962 Reduced 1.45%	65,340 $4.03 Million
Q2 2022 Jul 21, 2022	BUY	$57.72 - $65.01 $178,239 - $200,750	3,088 Added 4.88%	66,302 $4.1 Million
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $644,070 - $807,089	11,120 Added 21.35%	63,214 $3.76 Million
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $48,724 - $55,303	751 Added 1.46%	52,094 $3.75 Million
Q3 2021 Oct 13, 2021	BUY	$67.69 - $73.03 $110,131 - $118,819	1,627 Added 3.27%	51,343 $3.59 Million
Q2 2021 Jul 01, 2021	BUY	$63.47 - $69.35 $214,592 - $234,472	3,381 Added 7.3%	49,716 $3.42 Million
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $144,960 - $165,399	2,416 Added 5.5%	46,335 $3 Million
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $147,516 - $168,088	2,604 Added 6.3%	43,919 $2.56 Million
Q3 2020 Nov 05, 2020	BUY	$62.1 - $78.08 $4,347 - $5,465	70 Added 0.17%	41,315 $2.61 Million
Q2 2020 Jul 27, 2020	SELL	$72.34 - $84.0 $831,910 - $966,000	-11,500 Reduced 21.8%	41,245 $3.17 Million
Q1 2020 May 04, 2020	SELL	$62.63 - $80.22 $85,239 - $109,179	-1,361 Reduced 2.52%	52,745 $3.94 Million
Q4 2019 Feb 05, 2020	BUY	$61.62 - $67.78 $77,456 - $85,199	1,257 Added 2.38%	54,106 $3.52 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $229,599 - $253,437	3,673 Added 7.47%	52,849 $3.46 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $30,192 - $33,857	488 Added 1.0%	49,176 $3.32 Million
Q1 2019 May 02, 2019	BUY	$62.53 - $70.05 $1.29 Million - $1.44 Million	20,576 Added 73.19%	48,688 $3.17 Million
Q4 2018 Jan 18, 2019	SELL	$60.54 - $79.0 $1.24 Million - $1.62 Million	-20,493 Reduced 42.16%	28,112 $1.76 Million
Q3 2018 Nov 01, 2018	BUY	$71.28 - $78.92 $45,975 - $50,903	645 Added 1.34%	48,605 $3.75 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $49,762 - $58,046	767 Added 1.63%	47,960 $3.4 Million
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $140,508 - $171,295	1,929 Added 4.26%	47,193 $3.56 Million
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $206,121 - $241,957	2,897 Added 6.84%	45,264 $3.24 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $40,453 - $47,948	561 Added 1.34%	42,367 $3.43 Million
Q2 2017 Aug 07, 2017	BUY	N/A	41,806	41,806 $2.96 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Omega Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Omega Wealth Management LLC with notifications on news.

Account

Alpha Omega Wealth Management LLC Gilead Sciences, Inc. Transaction History